Manuela Papini

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Venues

Clinical, cosmetic and investigational dermatology

Journal of fungi (Basel, Switzerland)

Expert opinion on biological therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Silvia Crotti, Deborah Cruciani, Manuela Papini
Reply to Navarro-Fernandez, I. Nailing down Clinical Nuances. Comment on "Crotti et al. A Terbinafine Sensitive Trichophyton indotineae Strain in Italy: The First Clinical Case of tinea corporis and onychomycosis. J. Fungi 2023, 9 , 865". Journal of fungi (Basel, Switzerland) 10 (3) (2024)
Silvia Crotti, Deborah Cruciani, Manuela Papini
Reply to Navarro-Fernandez, I. Nailing down Clinical Nuances. Comment on "Crotti et al. A Terbinafine Sensitive Trichophyton indotineae Strain in Italy: The First Clinical Case of tinea corporis and onychomycosis. J. Fungi 2023, 9 , 865". Journal of fungi (Basel, Switzerland) 10 (3) (2024)
Marina Talamonti, Filomena Russo, Giovanna Malara, Katharina Hansel, Manuela Papini, Angelo Cattaneo, Aurora Parodi, Andrea Chiricozzi, Piergiorgio Malagoli, Federico Bardazzi, Valeria Brazzelli, Paolo Dapavo, Paolo Gisondi, Cristina Zane, Concetta Potenza, Franca Cantoresi, Maria-Concetta Fargnoli, Sara Trevisini, Pina Brianti, Leonardo Pescitelli, Giovanni Gigante, Marta Bartezaghi, Luisa Caputo, Elisabetta Aloisi, Antonio Costanzo, null null
Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study. Clinical, cosmetic and investigational dermatology 16 (2023)
Filomena Russo, Marco Galluzzo, Luca Stingeni, Severino Persechino, Leonardo Zichichi, Andrea Conti, Claudia Giofrè, Valentina Dini, Martina Vispi, Laura Atzori, Angelo Cattaneo, Aurora Parodi, Federico Bardazzi, Giuseppe Stinco, Paolo Dapavo, Giampiero Girolomoni, Maria Letizia Musumeci, Manuela Papini, Marina Venturini, Stefano Dastoli, Sergio Di Nuzzo, Maria-Concetta Fargnoli, Gianluca Pagnanelli, Nicoletta Bernardini, Daniele Mario Gambini, Piergiorgio Malagoli, Carlo Mazzatenta, Ketty Peris, Iris Zalaudek, Gabriella Fabbrocini, Francesco Loconsole, Camilla Vassallo, Lucia Pietroleonardo, Francesca Prignano, Chiara Franchi, Anna Maria Offidani, Claudio Bonifati, Vito Di Lernia, Giovanni Gigante, Marta Silvia Bartezaghi, Matteo Franchi, Paola Ursoleo, Elisabetta Aloisi
Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study. Clinical, cosmetic and investigational dermatology 16 (2023)
Filomena Russo, Marco Galluzzo, Luca Stingeni, Severino Persechino, Leonardo Zichichi, Andrea Conti, Claudia Giofrè, Valentina Dini, Martina Vispi, Laura Atzori, Angelo Cattaneo, Aurora Parodi, Federico Bardazzi, Giuseppe Stinco, Paolo Dapavo, Giampiero Girolomoni, Maria Letizia Musumeci, Manuela Papini, Marina Venturini, Stefano Dastoli, Sergio Di Nuzzo, Maria-Concetta Fargnoli, Gianluca Pagnanelli, Nicoletta Bernardini, Daniele Mario Gambini, Piergiorgio Malagoli, Carlo Mazzatenta, Ketty Peris, Iris Zalaudek, Gabriella Fabbrocini, Francesco Loconsole, Camilla Vassallo, Lucia Pietroleonardo, Francesca Prignano, Chiara Franchi, Anna Maria Offidani, Claudio Bonifati, Vito Di Lernia, Giovanni Gigante, Marta Silvia Bartezaghi, Matteo Franchi, Paola Ursoleo, Elisabetta Aloisi
Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study. Clinical, cosmetic and investigational dermatology 16 (2023)
Marco Galluzzo, Marina Talamonti, Nicoletta Bernardini, Andrea Chiricozzi, Clara De Simone, Claudio Bonifati, Pierluigi Bruni, Diotallevi Federico, Maria Esposito, Dario Graceffa, Katharina Hansel, Francesco Loconsole, Gaia Moretta, Cristina Mugheddu, Manuela Papini, Antonio Giovanni Richetta, Nevena Skroza, Laura Atzori, Maria-Concetta Fargnoli, Severino Persechino, Annamaria Offidani, Luca Stingeni, Ketty Peris, Concetta Potenza, Luca Bianchi
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year. Expert opinion on biological therapy (2022)

Manuela Papini.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Manuela Papini